TMEM240 and colorectal carcinoma: The hypermethylation of the TMEM240 promoter was detected in plasma circulating cell-free DNA from 13 of 25 (52.0%) CRC patients, but less TMEM240 promoter hypermethylation was detected in healthy subjects (12 of 42, 28.6%, Fig. 3 d and f).